Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban before intracranial stenting for symptomatic intracranial atherosclerotic stenosis
ChiCTR2000031935Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in cerebral arteriosclerosis and Cerebral atherosclerotic stenosis (ICAD) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: Incidence of in-stent thrombosis, Periprocedural new-onset stroke events and 1 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
cerebral arteriosclerosisCerebral atherosclerotic stenosis (ICAD)
Beyond the preview
Go deeper on ChiCTR2000031935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031935.